CordenPharma to Acquire Peptisyntha SA from Solvay
CordenPharma will acquire Peptisyntha SA, based in Belgium.
International Chemical Investors Group (ICIG) and the Solvay Group have formed an agreement under which ICIG will acquire Peptisyntha SA, the Brussels-based custom manufacturer of peptides. Upon closing of the deal, expected later this fall, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptide manufacturing.
Although the US sister company Peptisyntha Inc., located in Torrance, California, is not part of the transaction, certain customer relationships will be assumed by Peptisyntha in Brussels.
Source: CordenPharma
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
